OTC Derivatives Consolidated Tape: ESMA Names the First Provider

ByOfficer

On 6 July 2026 the European Securities and Markets Authority (ESMA) selected Etrading Software (Netherlands) B.V. to run the EU’s OTC derivatives consolidated tape, naming it the consolidated tape provider for over-the-counter derivatives under the Markets in Financial Instruments Regulation (MiFIR). It is the third and last asset class under Article 27da of MiFIR to have a selected CTP candidate, after bonds and shares and ETFs. It is also the first time ESMA has chosen a provider to consolidate OTC derivatives trade data across the Union into one public feed of price and volume, subject to authorisation and go-live.

For a reporting officer the first question is blunt: does this add anything to my filings? The short answer is that the selection changes a MiFIR post-trade transparency arrangement and leaves EMIR trade-repository reporting exactly where it was. The work it creates sits in reference data and in the transparency prints that feed the tape, well away from the EMIR reports an operations desk files every day.

Etrading Software was chosen after ESMA assessed its application against the MiFIR criteria, including data quality, resilience, and the dissemination of consolidated market data. ESMA Executive Director Natasha Cazenave called it an important milestone for transparency and a step towards delivering the MiFIR Review’s objectives.

Related reading: how the UK is building its own bond consolidated tape.

What ESMA selected, and for how long

The selection runs under the CTP selection procedure ESMA operates for each asset class in Article 27da of MiFIR. ESMA will now invite Etrading Software to apply for authorisation without delay. Once authorised, the firm operates the OTC derivatives consolidated tape for five years under ESMA’s direct supervision. The organisational requirements the provider itself must meet sit in Article 27h.

One detail matters for anyone modelling what the tape will show: the OTC derivatives tape disseminates post-trade data only. There is no pre-trade order-book layer for derivatives, the same design used for the bond tape and different from the shares and ETFs tape, which consolidates pre-trade and post-trade data. A common misread is that the tape already exists. It does not. Selection is the step before authorisation, and ESMA has not published a public go-live date, so the live feed should be treated as pending.

The dates that matter

  • 8 March 2024: the MiFIR review, Regulation (EU) 2024/791, published in the Official Journal, rebuilding the consolidated tape framework inside MiFIR, Regulation (EU) No 600/2014.
  • 3 February 2025: the designated publishing entity regime for post-trade transparency of OTC transactions became fully operational.
  • 3 July 2025: ESMA selected Ediphy (fairCT) as the consolidated tape provider for bonds.
  • 19 December 2025: ESMA selected EuroCTP as the consolidated tape provider for shares and ETFs.
  • 5 January 2026: ESMA launched the selection procedure for the OTC derivatives tape; applications closed on 11 February 2026.
  • 6 July 2026: ESMA selected Etrading Software (Netherlands) B.V. as the OTC derivatives consolidated tape provider.
  • Next: authorisation without delay, then a five-year operating term under ESMA supervision. No public go-live date yet.

Why this is a MiFIR event while your EMIR reports stay put

EMIR, Regulation (EU) No 648/2012 as amended by EMIR REFIT, Regulation (EU) 2019/834, requires counterparties to report their derivative contracts to a trade repository under Article 9. That is confidential regulatory reporting: field-heavy, submitted to a registered trade repository, read by supervisors.

The consolidated tape consumes something separate. It aggregates MiFIR post-trade transparency data into one continuous electronic stream of price and volume per instrument. That data is published by trading venues or through APAs; where a DPE is responsible for an OTC transaction, the DPE makes the transaction public through an APA. Nothing in the 6 July decision amends an EMIR field, a trade-repository submission, or a reporting deadline. If your EMIR REFIT reports validated cleanly under the reporting standards that applied from 29 April 2024, the CTP selection does not add a field or touch a schema. For a refresher on the trade-repository side, see our EMIR reporting guide.

Who is responsible for the OTC prints that feed the tape

The tape is only as useful as the transparency data flowing into it, so the sharper question for firms is who publishes those OTC prints in the first place. The MiFIR review answered it with the designated publishing entity, or DPE, introduced in Article 21a. Investment firms apply to their national competent authority for DPE status. When a DPE is a party to a transaction, it makes that OTC transaction public through an APA. Where one side is a DPE, that side publishes; where neither party or both parties are DPEs, the seller makes the trade public.

DPE status is a lighter, opt-in publication route: a firm can take on the duty to make OTC transactions public without carrying the full obligations of a systematic internaliser. ESMA maintains a public register of DPEs and the instrument classes each one covers. The practical consequence is direct. The party that publishes the print is the party whose data quality lands on the tape for everyone to see.

The reference-data change that reaches your build

Two changes from the MiFIR review are where reporting and reference-data teams have genuine work. First, derivatives transparency moves off the ISIN. For public transparency the review points to the ISO 4914 Unique Product Identifier (UPI), on the basis that the ISIN proved cumbersome for non-fungible derivatives, with the Commission specifying the identifying reference data by delegated act. Second, the trigger for derivatives transparency no longer depends on whether an instrument is traded on a trading venue. It attaches instead to derivatives with predefined characteristics, applies whether the trade happens on or off venue, and covers derivatives that are sufficiently standardised for the published data to mean something to the wider market. All exchange-traded derivatives stay in scope.

The UPI-versus-ISIN mismatch is the first place the two data models stop lining up, and a public tape makes that mismatch visible to supervisors and competitors. Teams that keyed transparency logic to the ISIN and to venue status should plan a real mapping exercise, not a config tweak.

What the tape raises the stakes on

MiFIR requires trading venues and APAs to transmit the relevant data to the CTP from go-live and links the CTP’s data-quality controls to the data received. For an individual firm the practical effect is future visibility. Once the tape is live, post-trade transparency errors will surface in a single consolidated stream that supervisors, competitors and clients can read. That rewards firms that treat their transparency prints with the same discipline they give a trade-repository submission. The wider ESMA effort to simplify EMIR, MiFIR and SFTR reporting runs in parallel and does not fold the tape into any of those return sets.

Frequently Asked Questions

Does the OTC derivatives tape create a new reporting obligation for my firm?

It does not create a new EMIR-style filing. The tape consolidates MiFIR post-trade transparency data that trading venues, APAs and designated publishing entities already publish. The duty to make OTC transactions public sits in Articles 21 and 21a of MiFIR and predates this selection.

Is this an EMIR change or a MiFIR change?

It is a MiFIR change. EMIR trade-repository reporting under Article 9 of Regulation (EU) No 648/2012 is unaffected by the selection of the consolidated tape provider.

When does the OTC derivatives tape go live?

ESMA has selected the provider and will invite it to apply for authorisation. Once authorised, the tape runs for five years under ESMA supervision. ESMA has not published a public go-live date, so the live feed should be treated as pending authorisation.

What is a designated publishing entity, and do I need to become one?

A DPE is a firm granted status by its national competent authority under Article 21a of MiFIR to publish OTC transactions through an APA without taking on systematic internaliser obligations. Whether registering makes sense depends on your trading profile and how often you are the party that would otherwise carry the publication duty.

Why does the tape use the UPI instead of the ISIN?

The MiFIR review points OTC derivatives transparency at the ISO 4914 Unique Product Identifier because the ISIN proved cumbersome for public transparency across non-fungible derivatives. The Commission specifies the exact identifying reference data by delegated act.

Does data on the tape replace what I report to a trade repository?

No. The tape carries public transparency data, while EMIR trade-repository data is confidential regulatory reporting read by supervisors. The two serve different purposes and are not interchangeable.

Who feeds the tape with OTC derivatives data?

Trading venues and APAs are the MiFIR data contributors that transmit data to the CTP. DPEs are not direct CTP data contributors; where a DPE is responsible for an OTC transaction, it makes the transaction public through an APA.

Related Articles

Key Takeaways

  • ESMA selected Etrading Software (Netherlands) B.V. as the OTC derivatives consolidated tape provider on 6 July 2026, the third EU tape after bonds and shares and ETFs.
  • This is a MiFIR post-trade transparency development. EMIR trade-repository reporting under Article 9 of Regulation (EU) No 648/2012 is unchanged.
  • The OTC derivatives tape disseminates post-trade data only, with no pre-trade layer.
  • Once authorised, the CTP operates for five years under ESMA’s direct supervision, and no public go-live date has been set.
  • The data feeding the tape is transmitted to the CTP by trading venues and APAs under Article 22a of MiFIR. DPEs do not transmit directly to the CTP; they determine which investment firm must make an OTC transaction public through an APA under Article 21a.
  • The reference-data work sits in the ISIN-to-UPI (ISO 4914) transition and the shift of derivatives transparency scope onto predefined characteristics, on or off venue.
  • The main practical stakes are future visibility: once the tape is live, post-trade transparency data quality will surface on one consolidated public feed.

Sources and References

What to line up before the OTC derivatives consolidated tape goes live

Two moves cover most of the exposure. Confirm that the path by which your OTC prints reach an APA is clean and monitored, because that data is about to become public in one place. Then confirm your reference data can carry the UPI for derivatives transparency alongside the ISIN you still use elsewhere. Leave your EMIR trade-repository reports where they are, and watch for ESMA’s authorisation decision and the eventual go-live notice for the tape itself.

Last updated: July 2026

Disclaimer: The information on RegReportingDesk.com is for educational and informational purposes only. It does not constitute legal, regulatory, tax, or compliance advice. Always consult your compliance officer, legal counsel, or the relevant supervisory authority for guidance specific to your institution.

Similar Posts